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Background
Till date, few broadly neutralizing antibodies are gener-
ated against HIV-1 and they have limited breadth and
potency against clade C viruses, which are predominant
worldwide and in India. Here we have produced nine
different human scFvs against the V3 region of HIV-1
envelope.
Methods
A V3 specific phage library was constructed from EBV
transformed B cells of a clade C HIV-1 infected Indian
patient, whose plasma exhibited good neutralization
potential against a panel of viruses. Diversity of the con-
structed phage library was analysed by DNA fingerprint-
ing of 10 randomly selected clones from the unselected
library using BstN1 enzyme. One round of biopanning
was done against HIV-1 consensus V3C and V3B pep-
tides. scFvs were than characterised for their binding,
specifity and expression profile. VH and VL genes of
anti-V3 scFvs were sequenced for their preferential gene
usage.
Results
DNA fingerprinting analysis of clones from unselected
library showed that 90% of clones in the library were
distinct. Thirty clones were randomly selected after bio-
panning. Nine clones showed binding in phage ELISA
and exhibited a unique DNA fingerprint. Soluble expres-
sion of the selected scFvs was checked by SDS-PAGE
and confirmed by Western blot. All the nine anti-V3
scFvs showed cross-reactivity against both the V3 pep-
tides and did not bind to unrelated peptides. Distribu-
tion of VH gene segments of these anti-V3 scFvs were
different, 56% (5/9) of scFvs used VH4, thirty 33% (3/9)
VH5 and 11% (1/9) showed VH3 gene usage. Among
the light chains, IGKV1 and IGKV3 were most preferen-
tially used gene segments. Further these scFvs displayed
a stable binding to V3 peptides in different denaturing
agents.
Conclusion
This is the first study to generate human anti-V3 scFvs
against HIV-1 clade C. Further characterization of these
scFvs for their neutralization potential and epitope map-
ping will provide useful information for immunogen
design.
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